Japan’s Efforts For ‘Zero’ Device Lag To Guide EU?
This article was originally published in PharmAsia News
Japan aims to achieve “zero” review lag for medical devices by introducing new measures for products coming into the system and taking action to speed up reviews of devices already underway. It is taking a different approach according to how urgent the review is, or how urgently the product is needed.
You may also be interested in...
Interview: Bassil Akra Speaks About Leaving TÜV-SÜD, Future Challenges, Opportunities And COVID-19 Realities
As Bassil Akra returned his office equipment and access card to his TÜV-SÜD offices in Munich amidst a welcome of balloons, Medtech Insight asked what this meant for him personally and what it will be like to start in consultancy during a pandemic.
EU MDR Panel Discussion: Why An Extra Year Is Not Really A Delay For The MDR – How To Survive Changing And Confusing Times
26 May 2020, the date that the Medical Device Regulation was originally due to apply in the EU, was a good time to take stock of where the medtech sector finds itself. Three of the most renowned and outspoken experts on the EU medical device regulatory system gave their views in this exclusive interview.
National authorities can renew notified body designations by conducting reviews that do not include on-site visits, overturning one of the most critical measures introduced in medical device regulations over the last seven years.